Lipidio Pharmaceuticals Inc. — Form D
Lipidio Pharmaceuticals Inc. of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2019-11-21. The offering totals $12.0M, of which $4.6M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2019-11-21
- Form: D
- Accession: 0001794644-19-000002
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $12.0M
- Amount sold: $4.6M
- Remaining: $7.4M
- Investors: 58
- Date of first sale: 2019-11-08
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-353962
Issuer
- Name: Lipidio Pharmaceuticals Inc.
- CIK: 0001794644
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 3570 CARMEL MOUNTAIN RD STE 200, SAN DIEGO, CA, 92130
- Phone: 8584368000
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| David Bullough | Director | San Diego, CA |
| J. Gordon Foulkes | Director | San Diego, CA |
| Daniel Gordon Petree | Director | San Diego, CA |
| J. Gordon Foulkes | Executive Officer | San Diego, CA |
More